Therapy (HBV)

New Compound Holds Anti-Hepatitis B Treatment Promise

Published in Hepatitis Weekly, June 25th, 2001

A new compound has been shown to be active against the hepatitis B virus (HBV) in laboratory experiments, the Hepatitis B Foundation announced June 7, 2001.

The drug, called Alkovir^TM, is a variant of natural sugars. Its mechanism of action is under investigation, but it appears to work in a different manner than the other hepatitis B drugs in use.

"This means we may have a new pathway of vulnerability to pursue against the disease," said Timothy Block, PhD, Hepatitis B Foundation. "We're extremely encouraged by the prospect of Alkovir emerging as a new weapon against hepatitis B."

The discovery, reported in the June...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-06-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry